CStone Pharmaceuticals (2616.HK) HKSE

7.45

-0.36(-4.61%)

Updated at September 26 04:08PM

Currency In HKD

CStone Pharmaceuticals

Address

New Bund Times Square

Shanghai, 201203

China

Phone

86 21 6033 5000

Sector

Healthcare

Industry

Biotechnology

Employees

135

First IPO Date

February 26, 2019

Key Executives

NameTitlePayYear Born
Dr. Jianxin Yang M.D., Ph.D.Chief Executive Officer, President of R&D and Executive Director7.86M1964
Mr. Michael J. Choi M.B.A.Chief Business & Strategy Officer01975
Dr. Qingmei Shi M.D., Ph.D.Senior Vice President & Chief Medical Officer01976
Ms. Weicong NiChief Financial Officer & Joint Company Secretary01991
Ms. Ying Hua ZhangSenior Vice President & Chief Operating Officer01979
Dr. Yujuan La Ph.D.Senior Vice President of Product Development01978
Ms. Mei Yee Yung FCIS, FCSJoint Company Secretary01965

Description

CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed death (PD) ligand 1; GAVRETO, an RET inhibitor for the treatment of patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor to treat adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation. The company's product pipeline includes Nofazinlimab, a PD-1 antibody for the treatment of patients with hepatocellular carcinoma; Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor to treat adults with relapsed or refractory acute myeloid leukemia with an IDH1 mutation; and Fisogatinib, an FGFR4 inhibitor to treat hepatocellular carcinoma. Its products also comprise CS1002, CS2006, CS3002, CS3005, CS2007, CS2008, and CS500 for solid tumors; and CS5001 for solid tumors and hematologic malignancies. The company was incorporated in 2015 and is headquartered in Shanghai, China.